Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Upper abdominal obesity, insulin resistance and breast cancer risk

International Journal of Obesity volume 26, pages 747–753 (2002)Cite this article

Abstract

Purpose: A majority of prospective studies show breast cancer risk to be higher in obese postmenopausal women with upper abdominal adiposity than in those with overall adiposity. The evidence is more limited and inconsistent in the case of premenopausal women. The review examines evidence that aberrant insulin signalling may be involved in the promotion of mammary carcinogenesis. The aetiology and concomitants of abdominal visceral obesity are examined.

Mechanisms: Clinical and experimental evidence suggests that the higher breast cancer risk associated with greater abdominal visceral obesity may be related to aberrant insulin signalling through the insulin receptor substrate 1 pathway, leading to insulin resistance, hyperinsulinaemia and increased concentrations of endogenous oestrogen and androgen. The putative role of aberrant insulin signalling in the promotion of mammary carcinogenesis may help to explain clinical relationships between breast cancer risk and age at menarche, pregnancies and onset of obesity.

Conclusion: Overall adiposity in women adversely affects breast cancer risk mainly by greater exposure of mammary epithelial tissue to endogenous oestrogen. Upper abdominal adiposity appears to involve an additional effect related to the presence of insulin resistance. Aetiological factors in the development of hyperinsulinaemic insulin resistance are still uncertain but may involve aberrant susceptibility genes in adipocyte insulin receptors or in the insulin receptor substrate 1 pathway. Epigenetic factors are also likely to contribute, including high free fatty acid levels and obesity. Dietary fatty acids, particularly polyunsaturated fatty acids, are known to regulate adipocyte differentiation through the nuclear peroxisome proliferator-activated receptor gamma, and may also have a role in insulin resistance. These aetiological factors are likely to be relevant to the high risk of postmenopausal breast cancer in industrialised Western populations.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Ballard-Barbash R, Schatzkin A, Carter CL, Kannel WB, Kreger BE, D'Agostino RB . Body fat distribution and breast cancer in the Framingham Study J Natl Cancer Inst 1990 82: 286–290.

    CAS  PubMed  Google Scholar 

  2. Folsom AR, Kaye SA, Prineas RJ, Potter JD, Gapstur SM, Wallace RB . Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausal women Am J Epidemiol 1990 131: 794–803.

    CAS  PubMed  Google Scholar 

  3. Kaaks R, van Noord PA, den Tonkelaar I, Peeters PJ, Riboli E, Grobbee DE . Breast cancer incidence in relation to height, weight and fat distribution in the Dutch DOM cohort Int J Cancer 1998 76: 647–651.

    CAS  PubMed  Google Scholar 

  4. Huang Z, Willett WC, Colditz GA, Hunter DJ, Manson JE, Rosner B, Speizer FE, Hankinson SE . Waist circumference, waist-hip ratio and risk of breast cancer in the Nurses' Health Study Am J Epidemiol 1999 150: 1316–1324.

    CAS  PubMed  Google Scholar 

  5. Sonnenschein E, Toniolo P, Terry MB, Bruning PF, Kato I, Koenig KL, Shore RE . Body fat distribution and obesity in pre- and postmenopausal breast cancer Int J Epidemiol 1999 28: 1026–1031.

    CAS  PubMed  Google Scholar 

  6. Muti P, Stanulla M, Micheli A, Krogh V, Freudenheim JL, Yang J, Schumeman HJ, Trevisan M, Berrino F . Markers of insulin resistance and sex steroid hormone activity in relation to breast cancer risk; a prospective analysis of abdominal adiposity, sebum production and hirsutism Cancer Causes Control 2000 11: 721–730.

    CAS  PubMed  Google Scholar 

  7. De Nino WF, Tchernof A, Dionne IJ, Toth MJ, Ades PA, Sites CK, Poehlman ET . Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy non-obese women Diabetes Care 2001 24: 925–932.

    CAS  Google Scholar 

  8. Stoll BA, Secreto G . New hormone-related markers of high risk to breast cancer Ann Oncol 1992 3: 435–438.

    CAS  PubMed  Google Scholar 

  9. Stoll BA . Western nutrition and the insulin resistance syndrome; a link to breast cancer Eur J Clin Nutr 1999 53: 83–87.

    CAS  PubMed  Google Scholar 

  10. Eckel RE . Insulin resistance; an adaptation for weight maintenance Lancet 1992 340: 1542–1543.

    Google Scholar 

  11. Schmitz-Peiffer C . Signalling aspects of insulin resistance in skeletal muscle; mechanisms induced by lipid oversupply Cell Signal 2000 12: 583–594.

    CAS  PubMed  Google Scholar 

  12. Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG . Hormonal risk factors, ‘breast tissue age’ and the age-incidence of breast cancer Nature 1983 303: 767–770.

    CAS  PubMed  Google Scholar 

  13. Cauley JA, Lucas FL, Kuller LE, Stone K, Browner W, Cummings SR . Elevated serum estradiol and testosterone concentrations are associated with high risk for breast cancer Ann Intern Med 1999 130: 270–277.

    CAS  PubMed  Google Scholar 

  14. Ballard-Barbash R . Anthropometry and breast cancer Cancer 1994 74: 1090–1100.

    CAS  PubMed  Google Scholar 

  15. Lemieux S, Prudhomme D, Bouchard C, Tremblay A, Despres JP . A single threshold value of waist-girth identifies subjects with excess visceral adipose tissue Am J Clin Nutr 1996 64: 685–693.

    CAS  PubMed  Google Scholar 

  16. Evans DJ, Hoffman RG, Kalkhoff BL, Kissebah AH . Relationship of androgenic activity to body fat topography, fat cell morphology and metabolic aberrations in premenopausal women J Clin Endocrinol Metab 1983 57: 304–310.

    CAS  PubMed  Google Scholar 

  17. Yu H, Rowan T . Role of the insulin-like growth factor family in cancer development and progression J Natl Cancer Inst 2000 92: 1472–1489.

    CAS  PubMed  Google Scholar 

  18. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M . Circulating concentrations of IGF1 and risk of breast cancer Lancet 1998 351: 1393–1396.

    CAS  PubMed  Google Scholar 

  19. Stewart AJ, Johnson MD, May FEB, Westley B . Roles of IGFs and IGF receptor on the oestrogen-stimulated proliferation of human breast cancer cells J Biol Chem 1990 265: 21172–21178.

    CAS  PubMed  Google Scholar 

  20. Thorsen T, Lahooti H, Rasmussen M, Aakvag A . Oestradiol treatment increases the sensitivity of MCF7 cells to the growth-stimulatory effects of IGF1 J Steroid Biochem Mol Biol 1992 41: 537–540.

    CAS  PubMed  Google Scholar 

  21. Clarke RH, Howell A, Anderson E . Type 1 IGF receptor gene expression in normal breast tissue treated with oestrogen and progesterone Br J Cancer 1997 75: 251–257.

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Kopelman PG, Albon L . Obesity, NIDDM and the metabolic syndrome Br Med Bull 1997 53: 322–340.

    CAS  PubMed  Google Scholar 

  23. Frayn KN . Visceral fat and insulin resistance; causative or correlative? Br J Nutr 2000 83 (Suppl 1): 71–77.

    Google Scholar 

  24. Lefebvre AM, Laville M, Vega N, Riou JP, Van Gaal L, Auwerx J, Vidal H . Depot-specific differences in adipose tissue gene expression in lean and obese subjects Diabetes 1998 47: 98–103.

    CAS  PubMed  Google Scholar 

  25. Kissebah AH, Vydelingum N, Murray R . Relation of body fat distribution to metabolic complications of obesity J Clin Invest 1982 54: 254–260.

    CAS  Google Scholar 

  26. Carey DG, Jenkins AB, Campbell LV, Freund J, Chisholm DJ . Abdominal fat and insulin resistance in normal and overweight women. Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM Diabetes 1996 45: 633–638.

    CAS  PubMed  Google Scholar 

  27. Goodpaster BH, Kelley DE, Wing RR, Meier A, Thaete FL . Effects of weight loss on regional fat distribution and insulin sensitivity in obesity Diabetes 1999 48: 839–847.

    CAS  PubMed  Google Scholar 

  28. Pollak M . Insulin-like growth factor physiology and cancer risk Eur J Cancer 2000 36: 1224–1228.

    CAS  PubMed  Google Scholar 

  29. Zierath JR, Livingston JN, Thorne A, Bolinder J, Reynisdottir S, Lonnqvist F, Arner P . Regional differences in insulin inhibition of NEFA release from human adipocytes; relation to insulin receptor phosphorylation and a signalling through the IRS-1 pathway Diabetologic 1998 41: 1343–1354.

    CAS  Google Scholar 

  30. Bjorntorp P . The regulation of adipose tissue distribution in humans Int J Obes Relat Metab Disord 1997 20: 291–302.

    Google Scholar 

  31. Armellini F, Zamboni M, Bosello O . Hormones and body composition in humans; clinical studies Int J Obes Relat Metab Disord 2000 24 (Suppl 2): 18–21.

    Google Scholar 

  32. De Pergola G, Zamboni M, Pannacciulli N, Turcato E, Giorgino F, Logoluso F, Sciaraffia M, Bosello O, Giorgino R . Divergent effects of short term, very low calorie diet on IGF1 and IGF-binding protein 3 serum concentrations in premenopausal women with obesity Obes Res 1998 6: 408–415.

    CAS  PubMed  Google Scholar 

  33. Rasmussen MH, Frystyk K, Andersen T, Breum L, Christiansen JS . The impact of obesity, fat distribution and energy restriction on IGF1, IGF-binding protein 3, insulin and growth hormone Metabolism 1994 43: 315–319.

    CAS  PubMed  Google Scholar 

  34. Dieudonne MN, Pecquery R, Boumediene A, Leneveu MC, Giudicelli Y . Androgen receptors in human preadipocytes and adipocytes; regional specificities and regulation by sex steroids Am J Physiol 1998 274 (Cell Physiol 43): 1645–1662.

    Google Scholar 

  35. Rebuffe-Scrive M, Lonnroth P, Marin E, Wesslau C, Bjorntorp P, Smith U . Regional adipose tissue metabolism in men and postmenopausal women Int J Obes 1987 11: 347–355.

    CAS  PubMed  Google Scholar 

  36. Haffner SM . Sex hormones, obesity, fat distribution, type 2 diabetes and insulin resistance; epidemiological and clinical correlation Int J Obes Relat Metab Disord 2000 24 (Suppl 2): 56–58.

    Google Scholar 

  37. Dieudonne MN, Pecquery R, Leneveu MC, Giudicelli Y . Opposite effects of androgens and estrogens on adipogenesis in rat pre adipocytes; evidence for sex- and site-related specificities and possible involvement of IGF1 receptor and AR gamma 2 Endocrinology 2000 141: 649–656.

    CAS  PubMed  Google Scholar 

  38. Vamecq J, Latruffe N . Medical significance of peroxisome proliferator-activated receptors Lancet 1999 354: 141–148.

    CAS  PubMed  Google Scholar 

  39. Latruffe N, Malki MC, Nicolas-Frances V, Clemencet M, Jannin B . Regulation of the peroxisome proliferator-activated receptor alpha and kinases Biochem Pharmac 2000 60: 1027–1032.

    CAS  Google Scholar 

  40. Valve R, Sivenius K, Miettinen R, Pihlajamaki J, Rissanen A, Deeb SS, Auwerx J, Usitupa M, Laakso M . Two polymorphisms in the AR gamma gene are associated with severe overweight among obese women J Clin Endocrinol Metab 1999 84: 3708–3712.

    CAS  PubMed  Google Scholar 

  41. Koch M, Rett K, Maerker E, Volk A, Haist K, Deninger M, Renn W, Haring HU . The AR gamma 2 amino acid polymorphism Pro 12 Ala is prevalent in offspring of type 2 diabetic patients and is associated to increased insulin sensitivity in a subgroup of obese subjects Diabetologia 1999 42: 758–762.

    CAS  PubMed  Google Scholar 

  42. Evans D, Mann WA, Heer J, Michel U, Wendt D, Kortner B, Wolf A, Beisiegel U . Variation in the gene for AR gamma does not play a major role in the development of morbid obesity Int J Obes Relat Metab Disord 2000 24: 647–651.

    CAS  PubMed  Google Scholar 

  43. Clement K, Hercberg S, Passinge B, Galan P, Varroud-Vial M, Shuldine AR, Beamer BA, Charpentier G, Guy-Grand B, Proguel P, Yaisse C . The Pro 115 Gln and Pro 12 Ala AR gamma mutations in obesity and type 2 diabetes Int J Obes Relat Metab Disord 2000 24: 391–393.

    CAS  PubMed  Google Scholar 

  44. De Pergola G . The adipose tissue metabolism; role of testosterone and dehydro-epiandrosterone Int J Obes Relat Metab Disord 2000 24 (Suppl 2): 59–63.

    Google Scholar 

  45. Minocci A, Savin G, Lucantoni R, Berselli ME, Tagliaferri M, Calo G, Petroni ML, de Medici C, Viberti GC, Liuzzi A . Leptin plasma concentrations are dependent on body fat distribution in obese patients Int J Obes Relat Metab Disord 2000 24: 1139–1144.

    CAS  PubMed  Google Scholar 

  46. Couillard C, Mauriege P, Imbeauet P, Prudhomme D, Nadeau A, Treml A, Bouchard C, Despres JP . Hyperleptinemia is more closely associated with adipose cell hypertrophy than with adipose tissue hyperplasia Int J Obes Relat Metab Disord 2000 24: 782–788.

    CAS  PubMed  Google Scholar 

  47. Kather H . Abstract in Ther Umsch 2000 57: 488–492 (translated from German)

  48. Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AMY . Migration patterns and breast cancer risk in Asian Americans J Natl Cancer Inst 1997 85: 1819–1827.

    Google Scholar 

  49. Clavel-Chapelon F, Launoy G, Auquier A . Reproductive factors and breast cancer risk; effect of age at diagnosis Ann Epidemiol 1995 5: 315–320.

    CAS  PubMed  Google Scholar 

  50. Frisch RE, McArthur JW . Menstrual cycles; fatness as a determinant of minimum weight for height necessary for their maintenance at onset Science 1974 185: 949–951.

    CAS  PubMed  Google Scholar 

  51. Cooper C, Kuh D, Egger P, Wadsworth M, Barker D . Childhood growth and age at menarche Br J Obstet Gynaecol 1996 103: 814–817.

    CAS  PubMed  Google Scholar 

  52. Frisancho AR, Flegel PN . Advanced maturation with centripetal fat pattern Hum Biol 1982 54: 717–727.

    CAS  PubMed  Google Scholar 

  53. Sherman B, Wallace R, Bean J, Schlabaugh L . Relationship of body weight to menarcheal and menopausal age; implications for breast cancer risk J Clin Endocrinol Metab 1980 52: 488–493.

    Google Scholar 

  54. Dipietro I, Mossberg HO, Stunkard AJ . A 40 y history of overweight children in Stockholm; lifetime overweight, morbidity and mortality Int J Obes Relat Metab Disord 1994 18: 585–590.

    CAS  PubMed  Google Scholar 

  55. Srinivasan SR, Myers L, Berenson GS . Temoral association between obesity and hyperinsulinaemia in children, adolescents and young adults. The Bogalusa Heart Study Metabolism 1999 48: 928–934.

    CAS  PubMed  Google Scholar 

  56. Savage MO, Smith CP, Dunger DB, Holly JM, Preece MA . Insulin and growth factors adaptation to normal puberty Hormone Res 1992 37 (Suppl 3): 70–73.

    CAS  PubMed  Google Scholar 

  57. Hunter D, Willett W . Diet, body size and breast cancer Epidemiol Rev 1993 15: 110–132.

    CAS  PubMed  Google Scholar 

  58. MacMahon B, Cole P, Lin TM . Age at first birth and breast cancer risk Bull WEO 1970 43: 209–221.

    CAS  Google Scholar 

  59. Trichopoulos D, Hsieh CC, MacMahon B . Age at any birth and breast cancer risk Int J Cancer 1983 31: 701–704.

    CAS  PubMed  Google Scholar 

  60. Kvale G, Heuch J . A prospective study of reproductive factors and breast cancer; age at first and last birth Am J Epidemiol 1987 126: 842–850.

    CAS  PubMed  Google Scholar 

  61. Albrektser G, Heuch I, Kvale G . Short- and long-term effect of pregnancy on breast cancer risk; a prospective study of 802,457 parous Norwegian women Br J Cancer 1995 72: 480–484.

    Google Scholar 

  62. Leon DA, Carpenter LM, Broeders MJ, Gunnarskog J, Murphy MF . Breast cancer in Swedish women before age 50; evidence of a dual effect of completed pregnancy Cancer Causes Control 1995 6: 283–291.

    CAS  PubMed  Google Scholar 

  63. Brown JE, Kaye SA, Folsom AR . Parity-related weight change in women Int J Obes Relat Metab Disord 1992 16: 627–631.

    CAS  PubMed  Google Scholar 

  64. Kaye SA, Folsom AR, Prineas RJ . Association of body fat distribution with lifestyle and reproductive factors in postmenopausal women Int J Obes 1990 14: 583–591.

    CAS  PubMed  Google Scholar 

  65. Stanley K, Fraser R, Bruce C . Physiological changes in insulin resistance in human pregnancy Br J Obstet Gynaecol 1998 105: 756–759.

    CAS  PubMed  Google Scholar 

  66. Sivan E, Homko CJ, Chen X, Reece EA, Boden G . Effect of insulin on fat metabolism during and after normal pregnancy Diabetes 1999 48: 834–838.

    CAS  PubMed  Google Scholar 

  67. Soltani H, Fraser RB . A longitudinal study of maternal anthropometric changes in normal weight, overweight and obese women during pregnancy and postpartum Br J Nutr 2000 84: 95–101.

    CAS  PubMed  Google Scholar 

  68. Gerber M, Corpet D . Energy balance and cancers Eur J Cancer Prev 1999 8: 77–89.

    CAS  PubMed  PubMed Central  Google Scholar 

  69. Pathak DR, Whittemore AS . Combined effects of body size, parity and menstrual events on breast cancer incidence in seven countries Am J Epidemiol 1992 135: 153–168.

    CAS  PubMed  Google Scholar 

  70. Stoll BA . Teenage obesity in relation to breast cancer risk Int J Obes Relat Metab Disord 1998 22: 1035–1040.

    CAS  PubMed  Google Scholar 

  71. Huang Z, Hankinson SE, Colditz GA, Stampfer MJ, Hunter DJ, Hennekens CH, Rosner B, Speizer FE, Willett W . Dual effects of weight and weight gain on breast cancer risk JAMA 1997 278: 1407–1411.

    CAS  PubMed  Google Scholar 

  72. Erickson GF, Garzo VG, Magoffin DA . IGF1 regulates aromatase activity in human granulosa and granulosa luteal cells J Clin Endocrinol Metab 1989 69: 716–724.

    CAS  PubMed  Google Scholar 

  73. Zimmet PZ . Hyperinsulinaemia—how innocent a bystander? Diabetes Care 1993 16 (Suppl 3): 56–70.

    PubMed  Google Scholar 

  74. Lemieux S . Genetic susceptibility to visceral obesity and related clinical implications Int J Obes Relat Metab Disord 1997 21: 831–838.

    CAS  PubMed  Google Scholar 

  75. Samaras K, Spector TD, Nguyen TY, Baan K, Campbell LV, Kelly PJ . Independent genetic factors determine the amount and distribution of fat in women after the menopause J Clin Endocrinol Metab 1997 82: 781–785.

    CAS  PubMed  Google Scholar 

  76. Groop L . Genetics of the metabolic syndrome Br J Nutr 2000 83 (Suppl 1): 39–48.

    Google Scholar 

  77. Benecke H, Topak H, von zur Muhlen A, Schuppert F . A study of the genetics of obesity; influence of polymorphisms of the beta-3-adrenergic receptor and IRS 1 in relation to weight loss, waist-to-hip ratio and frequencies of common cardio-vascular risk factors Exp Clin Endocrinol Diabetes 2000 108: 86–92.

    CAS  PubMed  Google Scholar 

  78. Goran MI, Gower BA . Relation between visceral fat and disease risk in children and adolescents Am J Clin Nutr 1999 70 (Suppl): 149–156.

    Google Scholar 

  79. Lindheim SR, Presser SC, Ditkoff EC, Vijod MA, Stenczyk FZ, Lobo RA . A possible bimodal effect of estrogen on insulin sensitivity in postmenopausal women Fertil Steril 1993 60: 664–667.

    CAS  PubMed  Google Scholar 

  80. Weiderpass E, Gridley G, Persson I, Nyren O, Ekbom A, Adami HD . Risk of endometrial and breast cancer in patients with diabetes mellitus Int J Cancer 1997 71: 360–363.

    CAS  PubMed  Google Scholar 

  81. Talamini R, Franceschi S, Favero A, Negri E, Pavazzini F, La Vecchio C . Selected medical conditions and risk of breast cancer Br J Cancer 1997 75: 1699–1703.

    CAS  PubMed  PubMed Central  Google Scholar 

  82. La Vecchia C, Negri E, Franceschi S, D'Avalzo B, Boyle P . A case–control of diabetes mellitus and cancer risk Br J Cancer 1994 70: 950–953.

    CAS  PubMed  PubMed Central  Google Scholar 

  83. Adami HO, McLaughlin J, Ekbom A, Berne C, Silverman D, Hacker D, Persson I . Cancer risk in patients with diabetes mellitus Cancer Causes Control 1991 2: 307–314.

    CAS  PubMed  Google Scholar 

  84. Moore MA, Park CB, Tsuda H . Implications of the hyperinsulinaemia–diabetes–cancer link for preventive efforts Eur J Cancer Prev 1998 7: 89–107.

    CAS  PubMed  Google Scholar 

  85. Djursing H, Hagen C, Andersen M, Svenstrup B, Bennett P, Pedevsen L . Serum sex hormone concentrations in insulin-dependent diabetic women with and without amenorrhoea Clin Endocrinol 1985 23: 147–154.

    CAS  Google Scholar 

  86. Peyrat JP, Bonneterre J, Beuscart R, Djiane J, Demaille A . IGF-1 receptors in human breast cancer and their relation to estradiol and progesterone receptors Cancer Res 1988 48: 6429–6433.

    CAS  PubMed  Google Scholar 

  87. Stoll BA . Oestrogen/IGF-1 receptor interaction in early breast cancer; clinical implications Annl Oncol 2002 (in press)

Download references

Author information

Authors and Affiliations

  1. Oncology Department, St Thomas' Hospital, London, UK

    BA Stoll

Authors
  1. BA Stoll
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stoll, B. Upper abdominal obesity, insulin resistance and breast cancer risk. Int J Obes 26, 747–753 (2002). https://doi.org/10.1038/sj.ijo.0801998

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0801998

Keywords

This article is cited by

Search

Advanced search

Quick links